CompoAtlas

Atropex

Food supplement declared in France, declaration No 2023-7-1477, decision dated 26 July 2023

Atropex is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.

Brand
not provided
Food business operator placing the product on the market
LUSTREL LABORATOIRES
Status
Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
Form
Gélule
Daily dose
2 gélules par jour

Declaration 198147, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

None of the rules we check applies to the declared ingredients.

Declared composition

Other active ingredients

NamePer day
Méthioninenot declared
L-isoleucinenot declared
Bêta-alaninenot declared
Chlorhydrate de L-argininenot declared
L-cystinenot declared
Glutaminenot declared
Levure de bière inactivéenot declared

Additives

E470b

Other ingredients

Ovalbumine, gélatine

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

List recorded in 2023. Photograph the packaging to check whether it has changed.

Has the product changed? Photograph the packaging.

Label warnings

Il est conseillé aux femmesenceintes et allaitantes de prendre l’attache d’unprofessionnel de santé avant toute complémentation.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

List recorded in 2023. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line